Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease

(2019) Simon Sjödin et al.   Alzheimers Research & Therapy

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

(2019) Joseph F. Arboleda-Velasquez et al.   NATURE MEDICINE

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Subjective Cognitive Decline and APOE ɛ4: A Systematic Review

(2018) Jordan I. Ali et al.   JOURNAL OF ALZHEIMERS DISEASE

Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)

(2018) Jennifer N. Rauch et al.   Scientific Reports

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

(2017) Günter U. Höglinger et al.   MOVEMENT DISORDERS

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

(2017) Gunnar Brinkmalm et al.   Proteomics Clinical Applications

Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels

(2017) Jerome Robert et al.   eLife

Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases

(2016) Robert W. Mahley   CLINICAL CHEMISTRY

Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma

(2016) Alaina T. Baker-Nigh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

(2016) Niklas Mattsson et al.   Nature Communications

mixtools: AnRPackage for Analyzing Finite Mixture Models

(2015) Tatiana Benaglia et al.   Journal of Statistical Software

Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls

(2014) Eduardo Martínez-Morillo et al.   ACTA NEUROPATHOLOGICA

APOE and LRPAP1 gene polymorphism and risk of Parkinson’s disease

(2014) Neeraj Kumar Singh et al.   NEUROLOGICAL SCIENCES

APOE ε4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD

(2014) Emily N. Manning et al.   PLoS One

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42

(2014) Sebastian Palmqvist et al.   JAMA Neurology

High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia

(2013) Swetha Vijayaraghavan et al.   Alzheimers & Dementia

Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer’s Disease

(2013) Christian Schmidt et al.   American Journal of Alzheimers Disease and Other Dementias

Apolipoprotein E Genotypes in Mexican Patients with Parkinson's Disease

(2013) M.P. Gallegos-Arreola et al.   DISEASE MARKERS

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

(2013) Chia-Chen Liu et al.   Nature Reviews Neurology

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2

(2013) Sana Suri et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Impact of Genetic Variants of Apolipoprotein E on Lipid Profile in Patients with Parkinson's Disease

(2013) Michele L. Gregório et al.   Biomed Research International

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain

(2012) Xiao Zhang et al.   ACTA NEUROPATHOLOGICA

Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n= 669): A Pilot Assay for Methionine-containing Proteotypic Peptides

(2012) Romain Simon et al.   MOLECULAR & CELLULAR PROTEOMICS

A large study reveals no association between APOE and Parkinson's disease

(2012) Monica Federoff et al.   NEUROBIOLOGY OF DISEASE

Predictive value of APOE- 4 allele for progression from MCI to AD-type dementia: a meta-analysis

(2011) L. S. Elias-Sonnenschein et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Evaluation of absolute peptide quantitation strategies using selected reaction monitoring

(2011) James Campbell et al.   PROTEOMICS

Human apoE Isoforms Differentially Regulate Brain Amyloid-  Peptide Clearance

(2011) J. M. Castellano et al.   Science Translational Medicine

Influence of apolipoprotein E ɛ4 on rates of cognitive and functional decline in mild cognitive impairment

(2010) Danielle C. Whitehair et al.   Alzheimers & Dementia

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

(2010) Brendan MacLean et al.   BIOINFORMATICS

Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry

(2009) Kristin R. Wildsmith et al.   ANALYTICAL BIOCHEMISTRY

Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients

(2009) Jiguang Guo et al.   CELL RESEARCH

The Role of Apolipoprotein E in Alzheimer's Disease

(2009) Jungsu Kim et al.   NEURON

Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease

(2008) Mario Ezquerra et al.   NEUROSCIENCE LETTERS